...
首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >A COMPARATIVE STUDY OF EFFICACY AND SAFETY OF ORAL DICLOFENAC AND DECREASED DOSE OF DICLOFENAC PLUS TOPICAL DICLOFENAC IN TREATMENT OF KNEE OSTEOARTHRITIS
【24h】

A COMPARATIVE STUDY OF EFFICACY AND SAFETY OF ORAL DICLOFENAC AND DECREASED DOSE OF DICLOFENAC PLUS TOPICAL DICLOFENAC IN TREATMENT OF KNEE OSTEOARTHRITIS

机译:口服双氯芬酸和双氯芬酸加局部双氯芬酸治疗剂量减少的疗效和安全性比较研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objectives: To compare efficacy and safety of topical plus reduced dose of diclofenac to oral diclofenac in therapeutic dose. Method: The study was prospective, comparative and randomized, which included 50 patients suffering from knee osteoarthritis. Patients were randomized to receive either – oral diclofenac alone (50 mg thrice daily) (therapy1) or decreased dose of oral diclofenac and topical diclofenac (75 mg SR once daily + 10 mg Nanogel thrice daily) (therapy 2). The patients had been followed up for 7 days. Visual Analogue Scale and Lequesne Index has been used to evaluate the efficacy. Adverse drug reaction form, WHO and Naranjo Causality Assessment Scale were used to evaluate the safety of the patients. Data were analyzed by independent student t- test. Results: Out of 50 patients 17 were male and 33 were female. Osteoarthritis is more prevalent in 40-60 years of age, female patients and higher body weight and Body Mass Index (BMI). Therapy 2 was found statistically superior to therapy 1 on efficacy parameters (VAS Scale and Lequesne Index). Compliance was also better with therapy 2. Conclusion: Both therapies effective and well tolerated although therapy 2 is comparatively more effective and has more patient compliance than therapy 1. There was no ADR reported.
机译:目的:比较治疗剂量下局部用双氯芬酸加减量双氯芬酸与口服双氯芬酸的疗效和安全性。方法:该研究是前瞻性,比较性和随机性的,其中包括50例膝骨性关​​节炎患者。患者被随机分配接受-口服双氯芬酸(每天50 mg三次)(治疗1)或减少口服双氯芬酸和局部双氯芬酸的剂量(每天75 mg SR一次,每天三次10 mg Nanogel)(治疗2)。对患者进行了7天的随访。视觉模拟量表和Lequesne指数已用于评估疗效。药物不良反应表,WHO和Naranjo因果关系评估量表用于评估患者的安全性。数据通过独立的学生t检验进行分析。结果:50例患者中,男性17例,女性33例。骨关节炎在40-60岁年龄段的女性,较高的体重和体重指数(BMI)中更为普遍。发现在功效参数(VAS量表和Lequesne指数)方面,治疗2在统计学上优于治疗1。疗法2的依从性也更好。结论:尽管疗法2比疗法1相对更有效并且对患者的依从性更高,但两种疗法均有效且耐受性良好。尚无ADR报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号